{
 "PrintNo":"A3605","Session":2021,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2021-01-28T09:56:53.839614Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Insurance",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2022-01-05","Committee":"Insurance"}],
 "Actions":[
  {"Text":"REFERRED TO INSURANCE","Date":"2021-01-28","Chamber":"ASSEMBLY"},
  {"Text":"REFERRED TO INSURANCE","Date":"2022-01-05","Chamber":"ASSEMBLY"}
 ],
 "Sponsors":[{"ID":520,"Name":"Linda Rosenthal","Short":"ROSENTHAL L"}],
 "Title":"Relates to mandating insurance coverage for medical devices to treat withdrawal symptoms",
 "Summary":"Relates to mandating insurance coverage for medical devices and products to treat withdrawal symptoms which are approved by the food and drug administration.",
 "LawSection":"Insurance Law","LawCode":"Amd §§3216, 3221 & 4303, Ins L",
 "ActClause":"AN ACT to amend the insurance law, in relation to mandating insurance coverage for medical devices to treat withdrawal symptoms",
 "PreviousVersions":["A8268-2019"]
}